RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) (“the Company” or
“RegeneRx”) today announced that a new paper entitled, Thymosin β4
Prevents Cardiac Rupture and Improves Cardiac Function in Mice with
Myocardial Infarction , was published in the journal, Heart
Circulation Physiology , on July 11, 2014.
Castlight Health Conducts First-of-Its-Kind Analysis of The Leapfrog Hospital Survey's Safety and Quality Data, Examining Factors Such As Medication Errors, Maternity Care and High-Risk Surgeries
WASHINGTON , July 18, 2014 /PRNewswire-USNewswire/ -- The Leapfrog Group (Leapfrog) today issued the Results of 2013 Leapfrog Hospital Survey, an in-depth examination of seven key areas of hospital quality and safety: medication errors, maternity care, high-risk surgeries, Intensive Care Unit (ICU) physician staffing, serious adverse events, safety practices, and hospital-acquired conditions (HACs) – including infections in ICUs, pressure ulcers, and injuries.
NEW YORK, NY --
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.